P-glycoprotein (P-gp/Abcb1), Abcc2, and Abcc3 Determine the Pharmacokinetics of Etoposide
Jurjen S. Lagas, Alfred H. Schinkel(Oncode Institute), Maria L.H. Vlaming(Oncode Institute), Olaf van Tellingen(Dutch Cancer Society), Els Wagenaar(The Netherlands Cancer Institute), Jos H. Beijnen(The Netherlands Cancer Institute)
Cited by 95
Related Papers
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
|Proceedings of the National Academy of Sciences|1997|941
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
|Proceedings of the National Academy of Sciences|1997|884